US Patent 11136317 NADPH oxidase 4 inhibitors
Patent 11136317 was granted and assigned to Actelion on October, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 30, 2020
Date of Patent
October 5, 2021
Patent Applicant
Patent Application Number
20200130
Patent Inventor Names
Sylvia Richard-Bildstein
0
Martin Bolli
0
Patrick Sieber
0
Christoph Boss
0
Hamed Aissaoui
0
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11136317 NADPH oxidase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
